英迪纳维
化学
蛋白酶抑制剂(药理学)
蛋白酶
HIV-1蛋白酶
酶抑制剂
病毒学
人类免疫缺陷病毒(HIV)
立体化学
酶
生物化学
西达
病毒载量
病毒性疾病
生物
抗逆转录病毒疗法
作者
Maren Kuhnert,H. Steuber,Wibke E. Diederich
摘要
HTLV-1 protease (HTLV-1 PR) is an aspartic protease which represents a promising drug target for the discovery of novel anti-HTLV-1 drugs. The X-ray structure of HTLV-1 PR in complex with the well-known and approved HIV-1 PR inhibitor Indinavir was determined at 2.40 Å resolution. In this contribution, we describe the first crystal structure in complex with a nonpeptidic inhibitor that accounts for rationalizing the rather moderate affinity of Indinavir against HTLV-1 PR and provides the basis for further structure-guided optimization strategies.
科研通智能强力驱动
Strongly Powered by AbleSci AI